Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

29.91

+0.35 (1.18%)

At close: Dec 5, 2025, 4:00 PM EST

29.92

0.00 (0.02%)

After-hours: Dec 5, 2025, 5:01 PM EST

Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	4,369	2,208	777	293	1,012	-	Upgrade
Market Cap Growth	96.90%	184.18%	165.01%	-71.03%	-	-	Upgrade
Enterprise Value	4,241	1,775	579	-83	433	-	Upgrade
Last Close Price	29.91	16.75	7.96	3.10	11.26	-	Upgrade
PS Ratio	265.73	-	113.40	-	-	-	Upgrade
PB Ratio	13.33	5.50	3.29	0.87	2.06	-	Upgrade
P/TBV Ratio	14.49	5.50	3.29	0.87	2.06	-	Upgrade
EV/Sales Ratio	282.74	-	84.53	-	-	-	Upgrade
Debt / Equity Ratio	0.39	0.29	0.36	0.21	0.15	1.82	Upgrade
Asset Turnover	0.03	-	0.02	-	-	-	Upgrade
Quick Ratio	10.25	9.10	7.51	10.97	24.84	1.18	Upgrade
Current Ratio	10.57	9.25	8.00	11.42	25.52	1.30	Upgrade
Return on Equity (ROE)	-60.62%	-73.93%	-52.79%	-52.24%	-154.41%	-	Upgrade
Return on Assets (ROA)	-25.26%	-26.82%	-26.61%	-24.48%	-27.16%	-	Upgrade
Return on Capital (ROIC)	-26.63%	-29.91%	-29.46%	-27.01%	-30.24%	-	Upgrade
Return on Capital Employed (ROCE)	-51.00%	-38.80%	-53.40%	-51.80%	-23.00%	-337.00%	Upgrade
Earnings Yield	-5.55%	-10.67%	-19.44%	-73.73%	-37.73%	-	Upgrade
FCF Yield	-4.15%	-6.43%	-20.65%	-68.77%	-13.47%	-	Upgrade
Buyback Yield / Dilution	-25.82%	-19.02%	-2.97%	-24.26%	-401.11%	-	Upgrade

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q